Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; The role of ICAM-1 and adhesion

British Journal of Cancer

Volumn 108, Issue 3, 2013, Pages 564-569

  Viola, K ^a,b   Kopf, S ^a,b   Huttary, N ^a   Vonach, C ^a,b   Kretschy, N ^a,b   Teichmann, M ^a   Giessrigl, B ^a   Raab, I ^a   Stary, S ^a   Krieger, S ^a   Keller, T ^a   Bauer, S ^a   Hantusch, B ^a   Szekeres, T ^c   De Martin, R ^a   Jager W ^d   Mikulits, W ^b   Dolznig, H ^a   Krupitza, G ^a   Grusch, M ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ARACHIDONATE LIPOXYGENASE; BAICALEIN; CALVASCULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; SMALL INTERFERING RNA;

ARTICLE; BINDING KINETICS; BREAST CANCER; CELL ADHESION; CELL MIGRATION; CELL STRAIN MCF 7; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SPHEROID CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CHEMOTAXIS; ENDOTHELIUM, LYMPHATIC; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; NITRILES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHEROIDS, CELLULAR; SULFONES; TUMOR CELLS, CULTURED;

EID: 84875224126     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.485     Document Type: Article

References (24)

1. Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E, Georgiev G, Berezin V, Bock E, Rygaard J, Cao R, Cao Y, Lukanidin E (2001) The metastasis-associated Mts1 (S100A4) protein could act as an angiogenic factor. Oncogene 20: 4685-4695.
2. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, Rosier RN (2000) Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 60(23): 6557-6562.
3. Budinsky AC, Brodowicz T, Wiltschke C, Czerwenka K, Michl I, Krainer M, Zielinski CC (1997) Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro. Int J Cancer 71(6): 1086-1090.
4. Bolick DT, Orr AW, Whetzel A, Srinivasan S, Hatley ME, Schwartz MA, Hedrick CC (2005) 12/15-Lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kB. Artersioscler Thromb Vasc Biol 25(2): 2301-2307.
5. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC. NCCN Breast Cancer Clinical Practice Guidelines Panel (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7: 122-192.
6. Deryugina EI, Bourdon MA, Jungwirth K, Smith JW, Strongin AY (2000) Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer 86(1): 15-23.
7. Folmer F, Jaspars M, Solano G, Cristofanon S, Henry E, Tabudravu J, Black K, Green DH, Küpper FC, Aalbersberg W, Feussner K, Dicato M, Diederich M (2009) The inhibition of TNF-a induced NF-kB activation by marine natural products. Biochem Pharmacol 78: 592-606.
8. Honn KV, Tang DG, Grossi I, Duniec ZM, Timar J, Renaud C, Leithauser M, Blair I, Johnson CR, Diglio CA, Kimler VA, Taylor JD, Marnett LJ (1994) Tumour cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res 54: 565-574.
9. Honn KV, Grossi IM, Diglio CA, Wojtukiewicz M, Taylor JD (1989) Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction. FASEB J 3(11): 2285-2293.
10. Jenkinson SR, Barraclough R, West CR, Rudland PS (2004) S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer 90: 253-262.
11. Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, Keller T, Nagy-Bojarszky K, Huttary N, Raab I, Lackner K, Krautgasser K, Schachner H, Kaserer K, Rezar S, Madlener S, Vonach C, Davidovits A, Nosaka H, Hämmerle M, Viola K, Dolznig H, Schreiber M, Nader A, Mikulits W, Gnant M, Hirakawa S, Detmar M, Alitalo K, Nijman S, Offner F, Maier TJ, Steinhilber D, Krupitza G (2011) Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest 121(5): 2000-2012.
12. Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, Krupitza G (2010) Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 102(9): 1361-1370.
13. Nishimura A, Akeda K, Matsubara T, Kusuzaki K, Matsumine A, Masuda K, Gemba T, Uchida A, Sudo A (2011) Transfection of NF-kB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma. Cancer Gene Ther 18(4): 250-259.
14. Orlowski RZ, Baldwin Jr AS (2002) NF-kB as a therapeutic target in cancer. Trends Mol Med 8(8): 385-389.
15. Rice RL, Tang DG, Hddadi M, Honn KV, Taylor JD (1998) 12(S)-Hydroxyeicosatetraenoic acid increases microfilament content in B16a melanoma cells: a protein kinase-dependent process. Int J Cancer 77: 271-278.
16. Schmidt-Hansen B, Ornås D, Grigorian M, Klingelhöfer J, Tulchinsky E, Lukanidin E, Ambartsumian N (2004) Extracellular S100A4 (mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23: 5487-5495.
17. Schoppmann SF, Soleiman A, Kalt R, Okubo Y, Benisch C, Nagavarapu U, Herron GS, Geleff S (2004) Telomerase-immortalized lymphatic and blood endothelial cells are functionally stable and retain their lineage specificity. Microcirculation 11: 261-269.
18. Spector AA, Gordon JA, Moore SA (1988) Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res 27: 271-323.
19. Srivastava RK, Kurzrock R, Shankar S (2010) MS-275 sensitizes TRAILresistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. Mol Cancer Ther 9(12): 3254-3266.
20. Takenaga K, Nakamura Y, Endo H, Sakiyama S (1994) Involvement of S100-related calcium-binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn J Cancer Res 85: 831-839.
21. Tang DG, Timar J, Grossi IM, Renaud C, Kimler VA, Diglio CA, Taylor JD, Honn KV (1993) The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res 207: 361-375.
22. Uchide K, Sakon M, Ariyoshi H, Nakamori S, Tokunaga M, Monden M (2007) Cancer cells cause vascular endothelial cell retraction via 12(S)-HETE secretion; the possible role of cancer cell derived microparticle. Ann Surg Oncol 14: 862-868.
23. Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Kalt R, Krieger S, Vo TPN, Madlener S, Bauer S, Marian B, Hämmerle M, Kretschy N, Teichmann M, Hantusch B, Stary S, Unger C, Seelinger M, Eger A, Mader R, Jäger W, Schmidt W, Grusch M, Dolznig H, Mikulits W, Krupitza G (2011) NF-kB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br J Cancer 105(2): 263-271.
24. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119(6): 1429-1437.